To determine the clinical relevance of IGF2BP2 in CRPC, we analyzed the mRNA expression data for prostate cancer patients available in the GDC Data Portal (https://portal.gdc.cancer.gov/). This evidence concerns the gene IGF2BP2 and Familial prostate cancer.